FDA Compliance Experts Advise Against Treating Minor Changes As ‘Planned Deviations’

 
• By Bowman Cox
  
How to achieve compliant pharmaceutical manufacturing without resorting to oxymorons like 'planned deviations'
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet